Condition: Asthma · Wheeze · Hypersensitivity · Sponsor: LMU Klinikum
Despite its common occurrence, still little is known about pathomechanisms determining different wheeze and asthma trajectories and phenotypes in children, and those beginning in adulthood. Therefore, deciphering underlying determinants for different childhood and adult asthma phenotypes is urgently needed to develop personalized treatment approaches targeting distinct underlying mechanisms. Thereby, secondary prevention early in the disease process can also be achieved. The decoding of such mechanisms and their translation to the individual patient is the aim of the Disease Area Asthma Allergy of the 'German Centre for Lung Research' (DZL).
This description comes directly from the study's public registry record.
Esther Zeitlmann, Diplom · +49894400 · esther.zeitlmann@med.uni-muenchen.de
Bianca Schaub, MD · +49894400 · bianca.schaub@med.uni-muenchen.de
Always discuss trial participation with your own doctor first.
| University Children's Hospital Cologne, Department of Paediatric Allergology and Pneumology | Cologne, Germany | Recruiting |
| Medizinische Hochschule Hannover, Biomedical Research in Endstage and Obstructive Lung Disease | Hanover, Germany | Recruiting |
| Universitaetsklinikum Schleswig-Holstein, Klinik für Kinder- und Jugendmedizin, Airway Research Center North | Lübeck, Germany | Recruiting |
| Klinik für Kinder- und Jugendmedizin, Universitaetsklinikum Giessen und Marburg GmbH, Universities of Giessen and Marburg Lung Center | Marburg, Germany | Recruiting |
| Klinikum der Universitaet Muenchen, Comprehensive Pulmonary Center Munich | Munich, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02496468